SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as investors highlight its role as critical decentralized infrastructure, particularly following its integration into major DeFi ecosystems and its partnership with the U.S. Department of Commerce to provide on-chain macroeconomic data. Community discussions emphasize the project's institutional backing, revenue-sharing model through token buybacks, and its increasing relevance as a key player in the Real World Asset (RWA) sector.

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Journey Medical Corp is trending as investors react to the FDA approval of Emrosi and its upcoming commercial launch in the rosacea market. The community is actively discussing the drug's potential as a new standard of care, alongside ongoing analysis of the company's financial roadmap, insurance coverage progress, and strategic partnership opportunities to drive future revenue.

Herc Holdings, Inc. engages in the provision of equipment rental services. It also sells used equipment and contractor supplies, and provides repair, maintenance, equipment management services, safety training, and ancillary services. Its equipment for rent includes aerial, earthmoving, material handling, trucks and trailers, air compressors, compaction, and lighting. The company was founded in 1965 and is headquartered in Bonita Springs, FL.

Herc Holdings Inc

Herc Holdings is seeing increased investor attention as the community evaluates the company's valuation against recent financial performance and broader sector trends. Traders are actively discussing the stock's volatility and potential for a long-term rebound, while monitoring institutional activity and industrial sector shifts for signs of a breakout.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

ShapeShift FOX token is drawing intense investor attention as community members speculate on its potential for a massive rally, citing low market capitalization and strong utility as reasons to accumulate during market dips. While some users are frustrated by historical price volatility and lack of momentum, many are actively comparing it to other decentralized exchange tokens and calling for long-term holding in anticipation of a broader altcoin market surge.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is currently experiencing heightened volatility as investors weigh speculative excitement over its 11 million TPS performance claims and high-profile industry mentions against concerns regarding recent price drops and low liquidity. Community sentiment is deeply polarized, with some members aggressively accumulating on dips in anticipation of future fiat anchor and partnership announcements, while others remain skeptical, dismissing the project as a pump-and-dump scheme.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

NIGHT is experiencing intense community debate following its recent launch and airdrop, with investors divided between excitement over its privacy-focused technology and skepticism regarding its ties to Cardano and perceived lack of decentralization. Traders are closely monitoring critical support levels while reacting to concerns about potential selling pressure and the project's long-term integration with platforms like Google Cloud.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is experiencing significant volatility as market participants debate its long-term viability, with the community split between those accumulating at lower price levels and those frustrated by stalled adoption and performance relative to the broader crypto market. Investors are closely monitoring key technical support levels and awaiting clarity on the project's development roadmap and potential ecosystem news.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is currently trending as users grapple with significant frustration over failed token claims, accessibility issues, and perceived technical instability, fueling widespread speculation that the project is an exit scam. Meanwhile, some community members remain optimistic, actively sharing referral codes for their mining apps and defending the project's long-term potential as a legitimate, albeit complex, blockchain venture.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

Tron is generating significant community buzz driven by its heavy utilization for global stablecoin transfers and recent ecosystem integrations, including its bridge to the Base network. Investors are actively discussing the potential impact of strategic partnerships with platforms like Rumble and the project's consistent burn mechanics on its long-term market performance.

DLocal Ltd. engages in the business of simplifying and redefining online payments experience. It focuses on processing payment transactions which enables merchants to get paid from customers and to make payments to customers in emerging markets. The company was founded by Andrés Bzurovski Bay and Sergio Enrique Fogel Kaplan in 2016 and is headquartered in Montevideo, Uruguay.

DLocal Limited - Ordinary Shares Class A

DLocal Limited

dLocal is drawing significant attention as investors react to a stellar quarterly report featuring a major earnings beat, record payment volumes, and the launch of a new share buyback program. The community is actively debating the stock's potential for a re-rating, with many bulls focusing on the company's strong fundamentals and emerging market expansion while others closely monitor technical resistance levels and persistent short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Research Upgrades Eton Pharmaceuticals (NASDAQ:ETON) to Strong-Buy

Zacks Research upgraded shares of Eton Pharmaceuticals from a "hold" rating to a "strong-buy" rating in a report on Thursday...

Eton Pharmaceuticals (NASDAQ:ETON) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Eton Pharmaceuticals from a "hold" rating to a "buy" rating in a report on Saturday...

Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, HC Wainwright Analyst Says

HC Wainwright increased their target price on Eton Pharmaceuticals from $37.00 to $52.00 and gave the stock a "buy" rating in a report on Friday...

B. Riley Financial Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock

B. Riley Financial boosted their price target on Eton Pharmaceuticals from $26.00 to $31.00 and gave the company a "buy" rating in a report on Friday...

Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock

Craig Hallum boosted their price target on Eton Pharmaceuticals from $30.00 to $35.00 and gave the company a "buy" rating in a research note on Friday...

Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume Increase  - Still a Buy?

Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume Increase - Here's Why...

Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?

The mean of analysts' price targets for Eton Pharmaceuticals (ETON) points to a 49.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Eton Pharmaceuticals (NASDAQ:ETON) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Eton Pharmaceuticals (NASDAQ:ETON - Get Free Report) posted its earnings results on Thursday. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.07. The company had revenue of $21.28 million during the quarter, compared to analyst...

Eton Pharmaceuticals Q4 Earnings Call Highlights

Eton Pharmaceuticals (NASDAQ:ETON) reported fourth quarter 2025 product revenue of $21.3 million, an 83% increase from $11.6 million in the prior-year period, as the company highlighted continued growth in its base business, contributions from recent product relaunches, and the early rollout of its...

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -58.33% and +4.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

$ETON Q4 &#39;25 Earnings Results &amp; Recap

Eton Pharmaceuticals reported total net revenues of $79.95M for the twelve months ended December 31, 2025, an increase from $39.01M in 2024, resulting in a gross profit of $42.74M.

Stocktwits

Eton Pharmaceuticals Inc

 Q4 '25 Earnings Results & Recap

Eton Pharmaceuticals reported total net revenues of $79.95M for the twelve months ended December 31, 2025, an increase from $39.01M in 2024, resulting in a gross profit of $42.74M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.11	--	--	N/A
Q4 '25	$0.13	--	--	N/A
Q3 '25	$0.09	$0.04	-55.56%	MISSED
Q2 '25	$0.02	-$0.10	-528.58%	MISSED
Q1 '25	$0.05	-$0.06	-212.50%	MISSED

ETON
Eton Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ETON News

ETONEton Pharmaceuticals Inc